These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3840949)

  • 101. Didemnin B. The first marine compound entering clinical trials as an antineoplastic agent.
    Chun HG; Davies B; Hoth D; Suffness M; Plowman J; Flora K; Grieshaber C; Leyland-Jones B
    Invest New Drugs; 1986; 4(3):279-84. PubMed ID: 3546184
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Preclinical antitumor activity of CI-994.
    LoRusso PM; Demchik L; Foster B; Knight J; Bissery MC; Polin LM; Leopold WR; Corbett TH
    Invest New Drugs; 1996; 14(4):349-56. PubMed ID: 9157069
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Mitomalcin: a new proteinaceous antileukemic antibiotic produced by Streptomyces malayensis (nov. sp.).
    McBride TJ; Axelrod M; Cullen WP; Marsh WS; Sodano CS; Rao KV
    Proc Soc Exp Biol Med; 1969 Apr; 130(4):1188-90. PubMed ID: 5779999
    [No Abstract]   [Full Text] [Related]  

  • 104. Cytotoxicity of cinnamic aldehyde on leukemia L1210 cells.
    Moon KH; Pack MY
    Drug Chem Toxicol; 1983; 6(6):521-35. PubMed ID: 6653439
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Studies on macromomycin, an antitumor protein.
    Im WB; Chiang CK; Montgomery R
    J Biol Chem; 1978 May; 253(9):3259-64. PubMed ID: 641069
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Action of the peptide antibiotic leucinostatin.
    Ishiguro K; Arai T
    Antimicrob Agents Chemother; 1976 Jun; 9(6):893-8. PubMed ID: 945714
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Antimetabolite-induced increases in the invasive capacity of murine leukaemia L1210 cells.
    De Graaf TW; Peters GJ; van Dijk W
    Clin Exp Metastasis; 1994 Mar; 12(2):134-42. PubMed ID: 8306527
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Cytotoxicity of poly(phenolic)sulfonates and their sodium salts in l1210 lymphoid leukemia cells.
    Wang F; Warren AE; Barnes CR; Hall IH
    Met Based Drugs; 1998; 5(3):147-60. PubMed ID: 18475836
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Synthesis and cytotoxicity of cyanoborane adducts of n6-benzoyladenine and 6-triphenylphosphonylpurine.
    Scarlett TC; Durham RW; Hall IH; Crosswicks RJ; Berkowitz JD; Burnham BS
    Met Based Drugs; 2002; 9(1-2):19-32. PubMed ID: 18475422
    [TBL] [Abstract][Full Text] [Related]  

  • 110. The cultivation of animal cells in the chemostat: application to the study of tumor cell multiplication.
    Tovey MG
    Adv Cancer Res; 1980; 33():1-37. PubMed ID: 6161528
    [No Abstract]   [Full Text] [Related]  

  • 111. The effects of boron containing peptides on L1210 lymphoid leukemia metabolism.
    Hall IH; Hall ES; Miller MC; Sood A; Spielvogel BF
    Amino Acids; 1993 Oct; 4(3):287-302. PubMed ID: 24190609
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Kinetic simulation of anticancer drug interactions.
    Jackson RC
    Int J Biomed Comput; 1980 May; 11(3):197-224. PubMed ID: 7203704
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Total and Formal Syntheses of Fostriecin.
    Dong G; Li B; O'Doherty G
    Org Chem Front; 2020 Nov; 7(22):3608-3615. PubMed ID: 33184589
    [TBL] [Abstract][Full Text] [Related]  

  • 114. High-Throughput Screening of
    Ehrenkaufer GM; Suresh S; Solow-Cordero D; Singh U
    Front Cell Infect Microbiol; 2018; 8():276. PubMed ID: 30175074
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Inhibitors of Serine/Threonine Protein Phosphatases: Biochemical and Structural Studies Provide Insight for Further Development.
    Swingle MR; Honkanen RE
    Curr Med Chem; 2019; 26(15):2634-2660. PubMed ID: 29737249
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Synthetic Strategies Employed for the Construction of Fostriecin and Related Natural Products.
    Trost BM; Knopf JD; Brindle CS
    Chem Rev; 2016 Dec; 116(24):15035-15088. PubMed ID: 28027648
    [TBL] [Abstract][Full Text] [Related]  

  • 117. De novo synthesis of natural products via the asymmetric hydration of polyenes.
    Wang Y; Xing Y; Zhang Q; O'Doherty GA
    Chem Commun (Camb); 2011 Aug; 47(30):8493-505. PubMed ID: 21559534
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Total synthesis of fostriecin: via a regio- and stereoselective polyene hydration, oxidation, and hydroboration sequence.
    Gao D; O'Doherty GA
    Org Lett; 2010 Sep; 12(17):3752-5. PubMed ID: 20687585
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Targeting protein serine/threonine phosphatases for drug development.
    McConnell JL; Wadzinski BE
    Mol Pharmacol; 2009 Jun; 75(6):1249-61. PubMed ID: 19299564
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Phase I and pharmacokinetic study of fostriecin given as an intravenous bolus daily for five consecutive days.
    Lê LH; Erlichman C; Pillon L; Thiessen JJ; Day A; Wainman N; Eisenhauer EA; Moore MJ
    Invest New Drugs; 2004 Apr; 22(2):159-67. PubMed ID: 14739664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.